Epstein Secrets

cessful execution of a business plan or the reduction in risk associated with achieving projected results." The framework of our analysis addresses Hardiman's concerns. The following section describes references to specific studies incorporating comparisons of Company-specific factors (e.g., revenues, ea

230 Requirements) CONFIDENTIAL I WTAS LLC EFTA00307397 WTAS ALIPHCOM — COMMON EQUITY VALUATION REPORT As of June 20, 2011 August 3, 2011 Mr. Michael Tamaru Chief Financial Officer AliphCom 99 Rhode Island Street, 3 ni floor San Francisco, CA 94103 Dear Mr. Tamaru: We have completed our analysis of

cessful execution of a business plan or the reduction in risk associated with achieving projected results." The framework of our analysis addresses Hardiman's concerns. The following section describes references to specific studies incorporating comparisons of Company-specific factors (e.g., revenues, ea

230 Requirements) CONFIDENTIAL I WTAS LLC EFTA00307296 WTAS ALIPHCOM — COMMON EQUITY VALUATION REPORT As of June 20, 2011 August 3, 2011 Mr. Michael Tamaru Chief Financial Officer AliphCom 99 Rhode Island Street, 3 ni floor San Francisco, CA 94103 Dear Mr. Tamaru: We have completed our analysis of

cessful execution of a business plan or the reduction in risk associated with achieving projected results." The framework of our analysis addresses Hardiman's concerns. The following section describes references to specific studies incorporating comparisons of Company-specific factors (e.g., revenues, ea

230 Requirements) CONFIDENTIAL I WTAS LLC EFTA00307195 WTAS ALIPHCOM — COMMON EQUITY VALUATION REPORT As of June 20, 2011 August 3, 2011 Mr. Michael Tamaru Chief Financial Officer AliphCom 99 Rhode Island Street, 3 ni floor San Francisco, CA 94103 Dear Mr. Tamaru: We have completed our analysis of